ERIN SVRCEK: Open Payments
NPI 1275867046 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,421 in 74 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,137 · 2025 $1,421
Food & beverage: $1,421
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $729 |
| Lilly USA, LLC | 8 | $120 |
| Novo Nordisk Inc | 5 | $120 |
| Abbott Laboratories | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $29 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Antares Pharma, Inc. | 1 | $24 |
Products named: UBRELVY, VRAYLAR, LINZESS, FREESTYLE LIBRE 3, QULIPTA, FARXIGA, KISUNLA, JARDIANCE.
Industry payments across MA — which companies pay providers there.
